[Histological margin and residual disease assessment for breast carcinoma]

B Sigal-Zafrani1, A Fourquet, A Vincent-Salomon

  • 1Département de biologie des tumeurs, de radiothérapie, Institut Curie, 26, rue d'Ulm, 75005 Paris, France. brigitte.sigal@curie.net

Related Concept Videos